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Previewsmay act as a surrogate; when bridging a
positively charged residue (e.g., Arg,
Figure 2E), a negatively charged ion
is required. Checking all vertebrate gluta-
mate receptors that include iGluRs but
also metabotropic glutamate receptors
(mGluRs) that are G protein coupled
receptors, basic residues binding thedistal g-carboxylate of glutamate are
only found among mGluRs. Thus, one
may wonder if AvGluR1 may be consid-
ered as an evolution stage of iGluRs
or a divergent branch, leaving open
the question of how bacterial iGluRs
evolved to AMPA, kainite, and NMDA
receptors.Structure 21, March 5, 2013REFERENCES
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G protein-coupled receptors mediate a wide array of physiologic stimuli and, together with their regulators
such as RGS2, are essential components of cellular signaling and function. RGS2 is a selective inhibitor of
the Gaq class of a subunits. In this issue of Structure, Nance and colleagues provide structural insight into
the features of RGS2 that mediate its potent and selective regulation of Gaq function.Signal transduction by G protein-coupled
receptors (GPCRs) controls a wide array
of physiological processes in eukaryotic
organisms. Thus, a protein that can selec-
tively regulate the magnitude, kinetics,
and fidelity of signaling via GPCRs is
critically important for the integration
and control of diverse cellular processes
such as nociception, cardiac pace-
making, cell migration, and apoptosis.
Regulator of G protein signaling (RGS)
proteins are important regulators of
GPCR signaling and, therefore, cell
physiologic processes. There are >35
members of the RGS protein superfamily
that have been identified in the human
genome. These proteins may be classi-
fied into one of several subfamilies (RZ,
R4, R7, R12, RA, GEF, GRK, SNX, and
D-AKAP) depending on their architectural
organization. Each RGS protein is typified
by an 120 amino acid RGS homology
(RH) domain. In the case of roughly 50%
of these proteins, the RH domain exhibits
guanosine triphosphatase (GTPase)-acti-
vating protein (GAP) activity toward one
or more G protein a subunits and thus
serves to regulate GPCR signaling (Ber-
man et al., 1996). From a biochemical
perspective, these RH domains exert theircatalytic function by binding to the three
flexible switch domains (SwI–III) on the
Ga subunit in a manner that stabilizes
the transition state-like conformation for
GTPase hydrolysis.
Since the discovery of RGS proteins in
the mid-1990s, several investigators
have explored the possibility that each
RGS family member may selectively regu-
late a specific subset of biologic signaling
pathways. Such pathway specificity for
an RGS protein might be based on its
cell-type restricted gene expression or
even its geographical compartmentali-
zation within specific effector cells. Both
of these elements are in place for RGS9-
1, a terminator of phototransduction that
is mediated via rhodopsin and Gat in the
visual system. RGS9-1 expression is
essentially restricted to rod and cone cells
on the retina, and the RGS9-1 protein can
be selectively targeted to the rod-outer
segments via its interaction with the
RGS9-specific anchoring protein (Cowan
et al., 1998; Martemyanov et al., 2003).
Together, these characteristics make it
a potent and selective regulator of photo-
transduction events. Many RGS proteins,
however, do not show highly restricted
gene expression patterns or obviousintracellular compartmentalization, sug-
gesting the need for further refinement
of signaling selectivity at the level of the
individual RGS protein-Ga subunit pairs.
Indeed, some RGS protein family mem-
bers show remarkable binding selectivity
and regulation of specific Ga binding part-
ners. For example, members of the R7
(RGS6, RGS7, RGS9, and RGS11) and
R12 (RGS10, RGS12, and RGS14) RGS
protein subfamilies appear to be specific
for Gai/o subunits (Cho et al., 2000; Soun-
dararajan et al., 2008). By contrast, one
member of the R4 subfamily, RGS2,
appears to shows a strong biochemical
preference for interaction with Gaq (Hex-
imer et al., 1997). A study by Nance
et al. (2013) in this issue of Structure
identifies additional sets of structural
determinants that help to mediate the
biochemical selectivity of RGS2 for Gaq.
Previous work by our group and others
pointed to the importance of three unique
residues in RGS2 (relative to other R4
group proteins) as key determinants of
its preference for interaction with Gaq
over Gai (Heximer et al., 1999, Kimple
et al., 2009). The replacement of all three
of these residues with the corresponding
residues from RGS4 was sufficient toª2013 Elsevier Ltd All rights reserved 319
Structure
Previewseliminate the selectivity of the RGS4
protein for Gaq and allow it to bind GAP
members of the Gai subclass. By com-
paring the putative location of these resi-
dues to their analogous positions in the
RGS4/Gai crystal structure, two of these
residues (C106 and N184) were predicted
to be located within a region of RGS2
that makes important contacts with a
conserved threonine residue in the switch
I region of the a subunit, while the third
residue (E191) was predicted to lie
outside the canonical RGS-Ga interface
in a region that was in close proximity to
the all-helical (aA) domain of the alpha
subunit. The crystal structure of the
RGS2SDK/Gai3 complex, where RGS2
was mutated to look like RGS4 at these
same three positions, indicated that the
overall RGS domain structure and mode
of Ga interaction may be similar between
RGS2 and RGS4 (Kimple et al., 2009).
However, in the absence of structural
data from the RGS2/Gaq complex, it re-
mained difficult to predict precisely how
these three selectivity determinants in
RGS2 might promote interaction with
Gaq and prevent interaction with Gai at
the same time.
New structural evidence from Nance
et al. (2013) shows that when wild-type
RGS2 binds to Gaq, the axis of the
RGS2 RH domain/Ga interaction is tilted
relative to that for the RGS2SDK/Gai3
complex discussed above, such that
a number of residues within the a7 helix
of the RGS2 RH domain are brought into
close contact with aA and the aB-aC
loop of the a-helical domain of Gaq. The
authors propose that this unique orienta-
tion is induced by the nature of the inter-
action between switch I residues in Ga
and the previously identified selectivity
residues in RGS2 (C106 and N184). They
further suggest that this pose is likely
tolerated by an inherently high degree of
flexibility within the a6 region that must
alter its conformation to maintain normal320 Structure 21, March 5, 2013 ª2013 Elsevinteractions with the switch III region of
Gaq. More importantly, they suggest
that the a7 region of RGS2 is uniquely
designed to accommodate this tilted
orientation and to promote its increased
affinity for Gaq relative to Gai. These
findings are significant, because they un-
cover a previously unappreciated region
of RGS2 that may contribute to its selec-
tivity and potency as GAP for Gaq.
Indeed, when the residues unique to the
RGS2 a7 helix are mutated, the authors
were able to show dramatic effects on
the ability of RGS2 to bind to Gaq and
regulate its function.
Moving forward, it will be important to
determine if other RGS2 binding partners
might exert either competitive or allosteric
effects on the a6 or a7 domains in
a manner that can affect the ability of
RGS2 to function as a potent inhibitor of
Gaq. For example, conditions that would
reduce the flexibility of the a6 domain
may be expected to dramatically reduce
the capacity of RGS2 to accommodate
its unique pose on RGS2. Likewise,
testing the importance of these domains
in intact cells will provide valuable infor-
mation regarding the biologic importance
of these newly identified specificity
residues in RGS2. Indeed, it has been
reported that RGS2 can behave as a
GAP for Gai in membrane-reconstituted
systems (Cladman and Chidiac, 2002)
but it is not understood how. Notably,
the interaction of the RGS2 amphipathic
helix with the inner leaflet of the plasma
membrane is known tomake an important
contribution to the function of RGS2 as an
inhibitor of Gaq (Gu et al., 2007). This
association would likely constrain the
number of degrees of freedom with
respect to orientation for the RGS2 RH
domain at the membrane, which, when
considering that Gaq and Gai are also
anchored to the plasma membrane, may
mean that these proteins typically engage
one another in a relatively well definedier Ltd All rights reservedmanner. It will thus be of considerable
interest to determine the relative roles of
the a7 domain and E191 in promoting
functional interaction between RGS2 and
Gaq in intact cells and, moreover, if any
of these same residues promote the
selectivity of this interaction by preventing
the association of RGS2 with Gai under
normal physiological circumstances.REFERENCES
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